Literature DB >> 30651334

Regulatory T Cells and Their Derived Cytokine, Interleukin-35, Reduce Pain in Experimental Autoimmune Encephalomyelitis.

Samuel S Duffy1, Brooke A Keating1, Chamini J Perera1, Justin G Lees1, Ryan S Tonkin1, Preet G S Makker1, Pascal Carrive1, Oleg Butovsky2, Gila Moalem-Taylor3.   

Abstract

Sensory problems such as neuropathic pain are common and debilitating symptoms in multiple sclerosis (MS), an autoimmune inflammatory disorder of the CNS. Regulatory T (Treg) cells are critical for maintaining immune homeostasis, but their role in MS-associated pain remains unknown. Here, we demonstrate that Treg cell ablation is sufficient to trigger experimental autoimmune encephalomyelitis (EAE) and facial allodynia in immunized female mice. In EAE-induced female mice, adoptive transfer of Treg cells and spinal delivery of the Treg cell cytokine interleukin-35 (IL-35) significantly reduced facial stimulus-evoked pain and spontaneous pain independent of disease severity and increased myelination of the facial nociceptive pathway. The effects of intrathecal IL-35 therapy were Treg-cell dependent and associated with upregulated IL-10 expression in CNS-infiltrating lymphocytes and reduced monocyte infiltration in the trigeminal afferent pathway. We present evidence for a beneficial role of Treg cells and IL-35 in attenuating pain associated with EAE independently of motor symptoms by decreasing neuroinflammation and increasing myelination.SIGNIFICANCE STATEMENT Pain is a highly prevalent symptom affecting the majority of multiple sclerosis (MS) patients and dramatically affects overall health-related quality of life; however, this is a research area that has been largely ignored. Here, we identify for the first time a role for regulatory T (Treg) cells and interleukin-35 (IL-35) in suppressing facial allodynia and facial grimacing in animals with experimental autoimmune encephalomyelitis (EAE). We demonstrate that spinal delivery of Treg cells and IL-35 reduces pain associated with EAE by decreasing neuroinflammation and increasing myelination independently of motor symptoms. These findings increase our understanding of the mechanisms underlying pain in EAE and suggest potential treatment strategies for pain relief in MS.
Copyright © 2019 the authors 0270-6474/19/392326-21$15.00/0.

Entities:  

Keywords:  IL-35; experimental autoimmune encephalomyelitis; multiple sclerosis; neuroinflammation; neuropathic pain; regulatory T cells

Mesh:

Substances:

Year:  2019        PMID: 30651334      PMCID: PMC6433755          DOI: 10.1523/JNEUROSCI.1815-18.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  76 in total

1.  Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice.

Authors:  C S Gillespie; D L Sherman; S M Fleetwood-Walker; D F Cottrell; S Tait; E M Garry; V C Wallace; J Ure; I R Griffiths; A Smith; P J Brophy
Journal:  Neuron       Date:  2000-05       Impact factor: 17.173

Review 2.  Multiple sclerosis: it's not the disease you thought it was.

Authors:  Loren A Rolak
Journal:  Clin Med Res       Date:  2003-01

3.  Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.

Authors:  Xingmin Zhang; Jayagopala Reddy; Hirofumi Ochi; Dan Frenkel; Vijay K Kuchroo; Howard L Weiner
Journal:  Int Immunol       Date:  2006-03-15       Impact factor: 4.823

Review 4.  Immune and inflammatory mechanisms in neuropathic pain.

Authors:  Gila Moalem; David J Tracey
Journal:  Brain Res Rev       Date:  2006-01-04

5.  P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury.

Authors:  Makoto Tsuda; Yukari Shigemoto-Mogami; Schuichi Koizumi; Akito Mizokoshi; Shinichi Kohsaka; Michael W Salter; Kazuhide Inoue
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

6.  IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.

Authors:  Xingmin Zhang; Djordje N Koldzic; Leonid Izikson; Jayagopala Reddy; Remedios F Nazareno; Shimon Sakaguchi; Vijay K Kuchroo; Howard L Weiner
Journal:  Int Immunol       Date:  2004-02       Impact factor: 4.823

7.  Hyperalgesia in an animal model of multiple sclerosis.

Authors:  Sue A Aicher; Marc B Silverman; Clayton W Winkler; Bruce F Bebo
Journal:  Pain       Date:  2004-08       Impact factor: 6.961

8.  p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain.

Authors:  Shan-Xue Jin; Zhi-Ye Zhuang; Clifford J Woolf; Ru-Rong Ji
Journal:  J Neurosci       Date:  2003-05-15       Impact factor: 6.167

9.  Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing.

Authors:  Camilla I Svensson; Martin Marsala; Anna Westerlund; Nigel A Calcutt; Wendy M Campana; Jason D Freshwater; Rosanne Catalano; Ying Feng; Andrew A Protter; Brian Scott; Tony L Yaksh
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

10.  Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.

Authors:  Mandy J McGeachy; Leigh A Stephens; Stephen M Anderton
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

View more
  21 in total

1.  Exogenous activation of tumor necrosis factor receptor 2 promotes recovery from sensory and motor disease in a model of multiple sclerosis.

Authors:  Roman Fischer; Tanja Padutsch; Valerie Bracchi-Ricard; Kayla L Murphy; George F Martinez; Niky Delguercio; Nicholas Elmer; Maksim Sendetski; Ricarda Diem; Ulrich L M Eisel; Richard J Smeyne; Roland E Kontermann; Klaus Pfizenmaier; John R Bethea
Journal:  Brain Behav Immun       Date:  2019-06-17       Impact factor: 7.217

2.  Tanshinone IIA Ameliorates CNS Autoimmunity by Promoting the Differentiation of Regulatory T Cells.

Authors:  Ye Gong; Yuan-Chu Liu; Xiao-Li Ding; Ying Fu; Lang-Jun Cui; Ya-Ping Yan
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

Review 3.  Qualitative sex differences in pain processing: emerging evidence of a biased literature.

Authors:  Jeffrey S Mogil
Journal:  Nat Rev Neurosci       Date:  2020-05-21       Impact factor: 34.870

4.  Low-dose interleukin-2 reverses chronic migraine-related sensitizations through peripheral interleukin-10 and transforming growth factor beta-1 signaling.

Authors:  Zhaohua Guo; Jintao Zhang; Xuemei Liu; Jacqueline Unsinger; Richard S Hotchkiss; Yu-Qing Cao
Journal:  Neurobiol Pain       Date:  2022-06-13

5.  Neuronal, stromal, and T-regulatory cell crosstalk in murine skeletal muscle.

Authors:  Kathy Wang; Omar K Yaghi; Raul German Spallanzani; Xin Chen; David Zemmour; Nicole Lai; Isaac M Chiu; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-26       Impact factor: 11.205

Review 6.  T Cells as Guardians of Pain Resolution.

Authors:  Annemieke Kavelaars; Cobi J Heijnen
Journal:  Trends Mol Med       Date:  2021-01-08       Impact factor: 11.951

Review 7.  Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.

Authors:  Claudia Selck; Margarita Dominguez-Villar
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

8.  Low-dose interleukin-2 reverses behavioral sensitization in multiple mouse models of headache disorders.

Authors:  Jintao Zhang; Katherine Czerpaniak; Liang Huang; Xuemei Liu; Megan E Cloud; Jacqueline Unsinger; Richard S Hotchkiss; Daizong Li; Yu-Qing Cao
Journal:  Pain       Date:  2020-06       Impact factor: 7.926

9.  Akt3-Mediated Protection Against Inflammatory Demyelinating Disease.

Authors:  Juwen C DuBois; Alex K Ray; Ross C Gruber; Yongwei Zhang; Ranee Aflakpui; Fernando Macian-Juan; Bridget Shafit-Zagardo
Journal:  Front Immunol       Date:  2019-07-25       Impact factor: 7.561

10.  In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse.

Authors:  Gil-Ran Kim; Won-Ju Kim; Sangho Lim; Hong-Gyun Lee; Ja-Hyun Koo; Kyung-Ho Nam; Sung-Min Kim; Sung-Dong Park; Je-Min Choi
Journal:  Adv Sci (Weinh)       Date:  2021-05-05       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.